Mirum Pharmaceuticals, Inc.MIRMNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
147.83%
↑ 103% above average
Average (28q)
-4888.70%
Historical baseline
Range
High:221.29%
Low:-141989.55%
Volatility
-2909.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 147.83% |
| Q2 2025 | 60.00% |
| Q1 2025 | 38.78% |
| Q4 2024 | -63.33% |
| Q3 2024 | 42.31% |
| Q2 2024 | 3.70% |
| Q1 2024 | 23.94% |
| Q4 2023 | -24.56% |
| Q3 2023 | 70.62% |
| Q2 2023 | -142.50% |
| Q1 2023 | 19.19% |
| Q4 2022 | 2.94% |
| Q3 2022 | -21.43% |
| Q2 2022 | 28.21% |
| Q1 2022 | -162.23% |
| Q4 2021 | 221.29% |
| Q3 2021 | -6.90% |
| Q2 2021 | 13.69% |
| Q1 2021 | -17.48% |
| Q4 2020 | -66.28% |
| Q3 2020 | 7.53% |
| Q2 2020 | -8.14% |
| Q1 2020 | -8.86% |
| Q4 2019 | 5.95% |
| Q3 2019 | -42.37% |
| Q2 2019 | 1.67% |
| Q1 2019 | 93.70% |
| Q4 2018 | -141989.55% |
| Q3 2018 | 0.00% |